James Kocsis is a Psychiatry physician affiliated with Cornell University. OpenAlex indexes 254 publications with 16,149 citations (h-index 65); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Psychiatry profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
525 E 68th St
Floor F-11
New York, NY 100654870
Telephone
212-746-5913Registry record last updated 10 Nov 2011.
Clinical trials
- Depression, Obesity and Inflammatory Markers
Sponsor: Weill Medical College of Cornell University
- Lexapro for Major Depression in Patients With Epilepsy
Sponsor: Weill Medical College of Cornell University
- Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
Sponsor: Weill Medical College of Cornell University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Global Services, LLCProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%SSRI24.8%Escitalopram Oxalate63%Trazodone Hcl38%Part D<11 patientsgamma-Aminobutyric Acid A Receptor Positive Modulator16.4%Zolpidem Tartrate68%Zolpidem Tartrate Er32%Part D<11 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 1985–2008 per NIH RePORTER. The latest:
- SAREDUTANT IN THE PREVENTION OF RELAPSE OF DEPRESSIVE SYMPTOMS
Weill Medical Coll of Cornell Univ
FY2007$1,222M01RR000047
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Acetyl- <scp>l</scp> -carnitine deficiency in patients with major depressive disorder
Proceedings of the National Academy of Sciences
2018 - Poor quality of life and functioning in bipolar disorder
International Journal of Bipolar Disorders
2017 - Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness)
The Journal of Clinical Psychiatry
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Devereux, MD
Cornell University
Thomas Walsh, MD
Cornell University
Cora Sternberg, MD
Cornell University
George Alexopoulos, MD
Cornell University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”